Navigation Links
Cardiovascular Disorders Drug Development Pipeline Review 2017: 1,200 Pipeline Products within the CVD Therapy Area - Research and Markets

DUBLIN, Apr. 10, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Cardiovascular Disorders Drug Development Pipeline Review, 2017" report to their offering.

The report provides comprehensive information on the pipeline development landscape for Hypertension, Dyslipidemia, Venous thromboembolism and Heart failure, from Discovery through to the Pre-Registration stage. This includes an analysis of products by stage of development, molecular target, mechanism of action (MoA), route of administration (RoA) and molecule type. A list of all products in development is provided, including dormant and discontinued projects. Finally, the report provides an overview of key players involved in the development of products in this area, and outlines recent updates and press releases in the field.

There are over 1,200 pipeline products within the CVD therapy area. Over 50% of these products are small molecules however there is also diversification with regards to molecule types within the pipeline. In addition, the molecular targets in the pipeline are considerably diverse with a high frequency of products acting on targets related to lipid metabolism and those which act on elements of the coagulation cascade.

Among those pipeline drugs expected for imminent release to market there is a mixture of first-in-class products, typically anti-dyslipidemia drugs aiming to provide alternatives to statin therapy, and drugs belonging to currently popular classes such as PCSK9 inhibitors and direct factor Xa inhibitors.

Key Topics Covered:

1. Research Report Guidance

2. Executive Summary

3. Introduction

4. Cardiovascular Disorders Report Coverage

5. Therapeutics Development

6. Therapeutics under Development by Companies

7. Therapeutics under Investigation by Universities/Institutes

8. Pipeline Products Glance

9. Products under Development by Companies

10. Products under Investigation by Universities/Institutes

11. Companies Involved in Therapeutics Development

12. Therapeutics Assessment

13. Discontinued Products

14. Product Development Milestones

15. Appendix

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

To view the original version on PR Newswire, visit:

SOURCE Research and Markets
Copyright©2017 PR Newswire.
All rights reserved

Related medicine technology :

1. Terumo Cardiovascular Group Announces New President and CEO, Robert DeRyke
2. World $114 Billion Site-Specific Drug Delivery Market, By Application (Pulmonary, Ocular, Oncology, CNS, Cardiovascular) - Forecasts to 2022 - Research and Markets
3. Cardiovascular Systems, Inc. Secures $40 Million Line of Credit from Silicon Valley Bank
4. Akcea Initiates Phase 2 Study of AKCEA-APO(a)-L Rx in Patients with High Lp(a) and Cardiovascular Disease
5. The Top 250 Developers of In-Vitro Diagnostics Tests for Cancer, Cardiovascular & Infectious Diseases
6. Innovative Cardiovascular Solutions Announces Successful First Cases in European Clinical Study of EMBLOK Embolic Protection System
7. Cardiac Holter Monitor Market to Reach US$518.9 Million by 2024: Rising Cases of Cardiovascular Diseases due to Sedentary Lifestyles Augment Demand, Observes TMR
8. Global Markets for Emerging Medical Device Technologies - Cardiovascular, Orthopedic, Neurology, Diabetes & In Vitro Diagnostics Markets - Research and Markets
9. Digital X-Ray System Market - Forecasts from 2016 to 2021 - Growing Incidents of Cardiovascular, Orthopedic & Dental Disorders Around the Globe - Research and Markets
10. True Health Chief Academic Officer and Cardiovascular Disease Expert to Lecture Before Miami Beach Symposium
11. New Supplement Based on Nobel Prize-Winning Research Boosts Nitric Oxide for Cardiovascular Health
Post Your Comments:
(Date:10/11/2017)... -- Caris Life Sciences ® , a leading innovator in ... medicine, today announced that St. Jude Medical Center,s Crosson ... as its 17 th member. Through participation with ... Institute will help develop standards of care and best ... cancer treatment more precise and effective. ...
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical ... innovative solutions for injectable drug administration, today shared the ... ID Adapter for improving the intradermal administration of polio ... Skin Vaccination Summit in May 2017 by Dr. ... Polio Department, World Health Organization (WHO), and recently published ...
(Date:10/4/2017)... -- According to the Centers for Disease Control and Prevention (CDC), influenza ... Care is helping communities across Massachusetts , ... no-cost* flu shots through the end of the month. *Some ... ... flu shot is by the end of October, according to the Centers ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... As health ... medicine known as “patient engagement.” The patient is doing more than filling out a ... , “There is an increasing emphasis in health care and research on the ...
(Date:10/13/2017)... ... 2017 , ... The International Association of Eating Disorders Professionals ... the field of eating disorders, announces the opening of early registration for the ... at the Omni Resort at ChampionsGate. , The annual iaedp™ Symposium ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Lori R. Somekh, ... member of ElderCounsel, a national organization of elder law and special needs planning attorneys. ... and rules. It also provides a forum to network with elder law attorneys nationwide,” ...
(Date:10/13/2017)... ... 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills is proud ... and unique items from across the nation, this holiday-themed event will raise funds and ... the VNA. The boutique will be open Saturday, November 4 (10:00 a.m. – ...
(Date:10/13/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a ... centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that ...
Breaking Medicine News(10 mins):